Mortality in craniopharyngiomas: Data from the last two decades

Area of Science:

• Neuro-oncology
• Endocrinology
• Oncology

Background:

• Craniopharyngiomas are rare epithelial tumors originating from the craniopharyngeal duct.
• Despite being histologically benign, they exhibit aggressive clinical behavior, characterized by invasiveness and high recurrence rates.
• Patients often present with significant comorbidities, impacting long-term survival.

Purpose of the Study:

• To summarize the current understanding of mortality associated with craniopharyngioma.
• To review standardized mortality ratios (SMRs) reported in recent literature.
• To identify established and potential predictors of mortality in craniopharyngioma patients.

Main Methods:

• Systematic review of studies published within the last 20 years.
• Analysis of reported standardized mortality ratios (SMRs).
• Compilation of data on causes of death and potential mortality predictors.

Main Results:

• Craniopharyngioma is associated with significantly high mortality, with SMRs ranging from 2.45 to 12.2.
• Cardiovascular diseases, respiratory diseases, and infections are identified as the leading causes of death.
• Older age at diagnosis is a consistent predictor of mortality, but other factors require further investigation.

Conclusions:

• Craniopharyngioma patients face a substantial mortality risk, underscoring the need for effective management strategies.
• Understanding the primary causes of death is crucial for developing targeted interventions.
• Further research is warranted to clarify the role of various factors in craniopharyngioma-related mortality.